trending Market Intelligence /marketintelligence/en/news-insights/trending/nxz6qidrc4ex0foca2t1ug2 content esgSubNav
In This List

Checkpoint Therapeutics appoints board member

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


Checkpoint Therapeutics appoints board member

Checkpoint Therapeutics Inc. added Christian Béchon to its board.

Béchon is the chairman and CEO of Paris-based ChB Consultants, a privately held life science consultancy company.

Prior to ChB, he was the chairman and CEO of LFB SA, a French biopharmaceutical company that specializes in biological medicinal products for treating serious and rare disorders.

New York-based Checkpoint Therapeutics is an immuno-oncology biopharmaceutical company that develops treatments for patients with solid tumor cancers.